Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal

Bayer secured three billion euros in equity from Apollo-managed funds. This deal involves its long-acting reversible contraceptives business. Apollo funds will take a minority…

Für die jahrelangen Glyphosat-Rechtsstreitigkeiten hat Bayer Milliarden ausgegeben und sich hoch verschuldet. Jetzt steigt Apollo bei einem Subunternehmen für Verhütungsmittel ein…

In the two weeks before and after Independence Day in the U.S., AstraZeneca signed potential billion-dollar licensing deals with CSPC Pharmaceutical and Sino Biopharmaceutical,…

Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal